In the last trading session, 3.22 million shares of the T2 Biosystems Inc (NASDAQ:TTOO) were traded, and its beta was 0.27. Most recently the company’s share price was $0.19, and it changed around -$0.02 or -7.43% from the last close, which brings the market valuation of the company to $5.45M. TTOO currently trades at a discount to its 52-week high of $6.95, offering almost -3557.89% off that amount. The share price’s 52-week low was $0.20, which indicates that the current value has fallen by an impressive -5.26% since then. We note from T2 Biosystems Inc’s average daily trading volume that its 10-day average is 1.16 million shares, with the 3-month average coming to 1.10 million.
T2 Biosystems Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 5 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 2 recommended TTOO as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. T2 Biosystems Inc is expected to report earnings per share of 0 for the current quarter.
T2 Biosystems Inc (NASDAQ:TTOO) trade information
Instantly TTOO has showed a red trend with a performance of -7.43% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.2400 on recent trading dayincreased the stock’s daily price by 20.83%. The company’s shares are currently down -53.71% year-to-date, but still down -14.36% over the last five days. On the other hand, T2 Biosystems Inc (NASDAQ:TTOO) is -46.01% down in the 30-day period. We can see from the shorts that 0.83 million shares have been sold at a short interest cover period of 1.26 day(s).
The consensus price target as assigned by Wall Street analysts is $5, which translates to bulls needing to increase their stock price by 96.2% from its current value. Analyst projections state that TTOO is forecast to be at a low of $5 and a high of $5.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 68.62%.
TTOO Dividends
T2 Biosystems Inc’s next quarterly earnings report is expected to be released in March.
T2 Biosystems Inc (NASDAQ:TTOO)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 10.17% of T2 Biosystems Inc shares, and 73.51% of them are in the hands of institutional investors. The stock currently has a share float of 81.83%.
Vanguard Extended Market Index Fund and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Sep 30, 2024 . The former held 229.85 shares worth $44682.0, making up 0.82% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 154.81 shares worth around $30095.0, which represents about 0.55% of the total shares outstanding.
